drugset / Trial / NCT05761002

Human Papilloma Virus Genotypes and Treatment Outcomes of Intralesional Immunotherapy of Anogenital Warts

NCT05761002

Unknown 58 enrolled Zagazig University
NaSingle-groupOpen-labelTreatment

Summary

This study aims to investigate the relationship between HPV genotypes and treatment outcomes of intralesional immunotherapy of anogenital warts with the quadrivalent vaccine (Gardasil).

Timeline

Start
2022-06-01
Primary completion
2023-06-01
Completion
2023-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Gardasil Vaccine 0.5 ml Intramuscular